国新健康圆满完成董事会、监事会换届选举

Core Points - The company successfully held its first extraordinary general meeting of shareholders in 2025, where the election of the twelfth board of directors and supervisory board took place [2][3] - Li Yonghua was elected as the chairman of the twelfth board of directors, and the meeting complied with all relevant laws and regulations [3] - A total of 293 shareholders participated in the voting, representing 285,603,057 shares, which accounted for 29.1042% of the total voting shares [2] Board and Supervisory Board Elections - The twelfth board of directors consists of 9 members, including 6 non-independent directors and 3 independent directors [2] - The supervisory board is composed of 3 members, with Cheng Zhipeng elected as the chairman [4] Management Appointments - The board appointed Yuan Hongquan as the general manager and several individuals to key management positions, including Liu Yingjie and Zhang Zhenhua as deputy general managers [6] - The appointments are effective from the date of approval by the board until the end of the twelfth board's term [6] Strategic Focus - The company aims to drive high-quality development through its strategic planning centered on "three medical collaborations, innovation-driven, and digital ecology" [9]